AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Pulmonx Corporation Common Stock
XNAS · usd
SIC 3841 · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
FIGI BBG001T4HJ52
1.83▼ 0.05 (-2.66%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
1.88
Day's Range
1.79 – 1.88
52-Week Range
1.13 – 2.89
Volume
227.8K
Avg Volume
266.1K
Share Statistics
Shares Outstanding
Employees
296
Exchange
XNAS
Listed
2020-10-01
Share count as of July 31, 2026

Pulmonx Corporation Common Stock (LUNG) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Pulmonx Corporation Common Stock (LUNG)
What is Pulmonx Corporation Common Stock's Market Cap?
Pulmonx Corporation Common Stock's Market Cap is $78.6M, based on as-reported figures from SEC (XBRL) filings.
What is Pulmonx Corporation Common Stock's Enterprise Value?
Pulmonx Corporation Common Stock's Enterprise Value is $60.3M, based on as-reported figures from SEC (XBRL) filings.
What is Pulmonx Corporation Common Stock's Price / Sales?
Pulmonx Corporation Common Stock's Price / Sales is 0.9×, based on as-reported figures from SEC (XBRL) filings.
What is Pulmonx Corporation Common Stock's EV / Revenue?
Pulmonx Corporation Common Stock's EV / Revenue is 0.7×, based on as-reported figures from SEC (XBRL) filings.
What is Pulmonx Corporation Common Stock's EV / EBITDA?
Pulmonx Corporation Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Pulmonx Corporation Common Stock's Revenue (TTM)?
Pulmonx Corporation Common Stock's Revenue (TTM) is $87.4M, based on as-reported figures from SEC (XBRL) filings.
What is Pulmonx Corporation Common Stock's Net Income (TTM)?
Pulmonx Corporation Common Stock's Net Income (TTM) is -$48.1M, based on as-reported figures from SEC (XBRL) filings.
What is Pulmonx Corporation Common Stock's EBITDA?
Pulmonx Corporation Common Stock's EBITDA is -$45.4M, based on as-reported figures from SEC (XBRL) filings.
What is Pulmonx Corporation Common Stock's Diluted EPS (TTM)?
Pulmonx Corporation Common Stock's Diluted EPS (TTM) is -1.12, based on as-reported figures from SEC (XBRL) filings.
What is Pulmonx Corporation Common Stock's EBITDA Margin?
Pulmonx Corporation Common Stock's EBITDA Margin is -51.9%, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · LUNGAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenue
YoY growth-4.6%-8.7%-4.9%+5.5%
Cost of goods sold
Gross profit
% of revenue78.0%77.9%77.6%74.7%
Operating expenses
Research and development
Selling, general and administrative
Total operating expenses
% of revenue117.8%140.9%121.4%141.6%
Loss from operations
% of revenue-39.8%-62.9%-43.8%-66.9%
Interest income
Interest expense
Other (expense) income, net
Net loss before tax
Net loss
% of revenue-44.3%-66.3%-46.1%-64.9%
Net loss per share attributable to common stockholders, basic (in dollars per share)
Net loss per share attributable to common stockholders, diluted (in dollars per share)